open/close global search bar

02 August 2012

Lecture

R. Tuder: Advances in our understanding of pulmonary vascular pathology: a global view

Comments (0)

Related Content

John Scandurra & Irene Lang - Implantable devices to improve pulmonary circulation compliance thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("John Scandurra & Irene Lang - Implantable devices to improve pulmonary circulation compliance", 65)}}
Kelly Chin - Efficacy and safety of initial triple oral versus initial double oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: Results of the randomised controlled TRITON study (NCT02558231) thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("Kelly Chin - Efficacy and safety of initial triple oral versus initial double oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: Results of the randomised controlled TRITON study (NCT02558231)", 65)}}
Shao-Liang Chen -PADN-5: Pulmonary arterial denervation in patients with pulmonary hypertension associated with left heart failure (NCT02220335) thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("Shao-Liang Chen -PADN-5: Pulmonary arterial denervation in patients with pulmonary hypertension associated with left heart failure (NCT02220335)", 65)}}
Ronald Oudiz - ABI-009, an mToR Inhibitor, for patients with severe pulmonary arterial hypertension (NCT02587325) thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("Ronald Oudiz - ABI-009, an mToR Inhibitor, for patients with severe pulmonary arterial hypertension (NCT02587325)", 65)}}
Erika Rosenzweig - A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: early experience in adolescents and adults thumbnail image

Conference talk

07 July 2020

{{GlobalController.truncateTitle("Erika Rosenzweig - A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: early experience in adolescents and adults", 65)}}

Add to reading list

Please enter a list name.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg